Paige DHeilly
Overview
Explore the profile of Paige DHeilly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fess L, Fell A, OToole S, DHeilly P, Holzbauer S, Kollmann L, et al.
Emerg Infect Dis
. 2024 Jun;
30(7):1352-1360.
PMID: 38916546
Accurate and timely mortality surveillance is crucial for elucidating risk factors, particularly for emerging diseases. We compared use of COVID-19 keywords on death certificates alone to identify COVID-19 deaths in...
2.
Guh A, Li R, Korhonen L, Winston L, Parker E, Czaja C, et al.
Open Forum Infect Dis
. 2024 Apr;
11(4):ofae127.
PMID: 38577028
Background: Because interventions are available to prevent further recurrence in patients with recurrent infection (rCDI), we identified predictors of multiple rCDI (mrCDI) in adults at the time of presentation with...
3.
Guh A, Yi S, Baggs J, Winston L, Parker E, Johnston H, et al.
Open Forum Infect Dis
. 2022 Sep;
9(9):ofac422.
PMID: 36072699
Among persons with an initial infection (CDI) across 10 US sites in 2018 compared with 2013, 18.3% versus 21.1% had ≥1 recurrent CDI (rCDI) within 180 days. We observed a...
4.
Ruhland A, Fell A, Holzbauer S, DHeilly P, Curtis K, Wick H, et al.
Clin Infect Dis
. 2022 Jun;
75(12):2247-2249.
PMID: 35684998
Healthcare personnel (HCP) are at potential risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in occupational and nonoccupational settings, even when fully vaccinated. This risk increased during Delta...
5.
Wiens T, Taylor J, Cole C, Saravia S, Peterson J, Lunda M, et al.
Public Health Rep
. 2021 Oct;
137(6):1053-1060.
PMID: 34694926
Objective: Electronic cigarette (e-cigarette), or vaping, product use-associated lung injury (EVALI) is a novel noncommunicable disease with an unknown cause. The objective of this analysis was to describe the Minnesota...
6.
Cole C, Wiens T, Taylor J, Danila R, DHeilly P, Margetta J, et al.
Minn Med
. 2021 Aug;
104(3):41-43.
PMID: 34413546
This report describes and contextualizes the high prevalence of mental health conditions (MHC) among Minnesota 2019 EVALI patients by examining the prevalence of MHC and associations between MHC and e-cigarette...
7.
Pecora N, Holzbauer S, Wang X, Gu Y, Taffner S, Hatwar T, et al.
J Infect Dis
. 2021 Jun;
225(1):121-129.
PMID: 34107037
Background: The distribution of Clostridioides difficile strains and transmission dynamics in the United States are not well defined. Whole-genome sequencing across 2 Centers for Disease Control and Prevention Emerging Infections...
8.
Fell A, Beaudoin A, DHeilly P, Mumm E, Cole C, Tourdot L, et al.
MMWR Morb Mortal Wkly Rep
. 2020 Oct;
69(43):1605-1610.
PMID: 33119557
Health care personnel (HCP) are at increased risk for infection with SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), as a result of their exposure to patients or community...
9.
Taylor J, Wiens T, Peterson J, Saravia S, Lunda M, Hanson K, et al.
MMWR Morb Mortal Wkly Rep
. 2019 Nov;
68(47):1096-1100.
PMID: 31774740
During August 9-October 31, 2019, 96 patients were classified as having e-cigarette, or vaping, product use-associated lung injury (EVALI) by the Minnesota Department of Health (MDH); other patients are being...